AuroraA/B/C抑制剂
| 英文名 | CCT137690 | CAS号 | 1095382-05-0 |
| 试剂别名 |
CCT137690;3-[[4-[6-bromo-2-[4-(4-methylpiperazin-1-yl)phenyl]-1H-imidazo[4,5-b]pyridin-7-yl]piperazin-1-yl]methyl]-5-methyl-1,2-oxazole;CCT-137690;3-((4-(6-bromo-2-(4-(4-methylpiperazin-1-yl)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)methyl)-5-methylisoxazole;3-((4-(6-bromo-2-(4-(4-methylpiperazin-1-yl)phenyl)-3H-imidazo-[4,5-b]pyridin-7-yl)piperazin-1-yl)methyl)-5-methylisoxazole;BCP9000498;cc-66;CHEBI:799254;CHEMBL1236904;CS-0706;SureCN4755249;6-Bromo-7-[4-[(5-methyl-3-isoxazolyl)methyl]-1-piperazinyl]-2-[4-(4-methyl-1-piperazinyl)phenyl]-3H-imidazo[4,5-b]pyridine;3-[[4-[6-Bromo-2-[4-(4-methylpiperazin-1-yl)phenyl]-3H-imidazo[4,5-b]pyridin-7-yl]piperazin-1-yl]methyl]-5-methylisoxazole
|
分子式 | C26H31BrN8O |
| 产品编号 | APEA4132 | 分子量 | 551.48 |
| MDL号 | MFCD18206879 |
| 产品名称： | AuroraA/B/C抑制剂 |
| 英文名称： | CCT137690 |
| 英文别名： | CCT137690;3-[[4-[6-bromo-2-[4-(4-methylpiperazin-1-yl)phenyl]-1H-imidazo[4,5-b]pyridin-7-yl]piperazin-1-yl]methyl]-5-methyl-1,2-oxazole;CCT-137690;3-((4-(6-bromo-2-(4-(4-methylpiperazin-1-yl)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)methyl)-5-methylisoxazole;3-((4-(6-bromo-2-(4-(4-methylpiperazin-1-yl)phenyl)-3H-imidazo-[4,5-b]pyridin-7-yl)piperazin-1-yl)methyl)-5-methylisoxazole;BCP9000498;cc-66;CHEBI:799254;CHEMBL1236904;CS-0706;SureCN4755249;6-Bromo-7-[4-[(5-methyl-3-isoxazolyl)methyl]-1-piperazinyl]-2-[4-(4-methyl-1-piperazinyl)phenyl]-3H-imidazo[4,5-b]pyridine;3-[[4-[6-Bromo-2-[4-(4-methylpiperazin-1-yl)phenyl]-3H-imidazo[4,5-b]pyridin-7-yl]piperazin-1-yl]methyl]-5-methylisoxazole |
| 中文别名： | 3-((4-(6-溴-2-(4-(4-甲基哌嗪-1-基)苯基)-3H-咪唑并[4,5-b]吡啶-7-基)哌嗪-1-基)甲基)-5-甲基异噁唑;3-[[4-[6-溴-2-[4-(4-甲基哌嗪-1-基) 苯基]-3H-咪唑并[4,5-b]吡啶-7-基]哌嗪-1-基]甲基]-5-甲基异恶唑;CCT137690 抑制剂;CCT137690 国华试剂;3-[[4-[6-溴-2-[4-(4-甲基哌嗪-1-基)苯基]-3H-咪唑并[4,5-b]吡啶-7-基]哌嗪-1-基]甲基]-5-甲基异恶唑 |
| CAS No.： | 1095382-05-0 |
| 分子式： | C26H31BRN8O |
| 分子量： | 551.48 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
